Respiratory Tracker: LAURA trial received close examination from HCPs

24.06.2024 | Tracker

Respiratory Tracker: LAURA trial received close examination from HCPs

Between 21 May and 20 June 2024, CREATION Pinpoint® tracked the conversations of UK online healthcare professionals (eHCPs) discussing respiratory diseases on X (Twitter). We analysed 2,000 posts discussing respiratory diseases by 876 eHCPs.

During the 2024 American Society of Clinical Oncology (ASCO) conference, held from May 31 to June 3, HCPs in the UK were very active online discussing respiratory diseases. When using the hashtag #ASCO24, more than half of these HCPs referenced non-small cell lung cancer (NSCLC).  

A key topic included AstraZeneca’s LAURA trial, discussed by seven UK HCPs in 15 posts. Some suggested data from the LAURA trial would potentially pave the way for a new standard of care for stage 3 EGFR-mutant NSCLC as it received a rousing ovation from the audience at ASCO. However some others, like oncologist Sanjay Popat, questioned whether the trial results were positive. 

HCPs also shared news about multiple trials and studies related to COPD, focusing particularly on medications and patient care. Emphasis was placed on the importance of recognising and managing COPD exacerbations and the use of rescue packs. In the same vein, HCPs celebrated Pulmonary Rehabilitation Week and the value of rehabilitation in COPD, bronchiectasis, pulmonary fibrosis and severe asthma management. 

A new initiative was also shared by four HCPs, the development of the myCOPD app to help patients with COPD manage their condition. The app, now recommended by NICE, will be enhanced with AI-enabled alerts

In June, UK HCPs shared their concerns about air pollution online. During awareness days like Clean Air Day, HCPs discussed the importance of addressing this issue. The detrimental impact of air pollution on children’s respiratory health was also highlighted. A manifesto and position statements were shared by HCPs as they called for ambitious new legislation to combat toxic air pollution and promote smoke-free generations. Clare Nash, a nurse in Bridgnorth, shared how ‘the disease burden attributable to air pollution reflects regional patterns of socioeconomic deprivation.

Each month, we track the eHCP conversation relating to respiratory disease. You can read other editions in the Respiratory Tracker archive .

You can also keep updated with other pharmaceutical tracking updates, including how eHCPs engage with Top 50 pharma and the product approvals that are catching their attention.  To receive updates straight to your inbox you can sign up for our monthly eJournal with our latest HCP insights.

 

Methodology

  • CREATION Pinpoint® was used to analyse 2,000 mentions on X from 876 HCPs in the UK discussing respiratory disease and related terms, between 21 May 2024 and 20 June 2024.

Share this article

Meet the Author

Doménica Carpio

Domé brings a unique mix of skills, combining an academic background in Media Communications and Project Management, all of which she uses to help pharmaceutical companies digest data and turn it into actionable insights.

Domé loves football, Middle Earth and quality time with friends.

Suggested next


05.07.2023 | Article

eHCPs at ASCO 23 are excited about new lung cancer data

What eHCPs were discussing in the lung cancer conversation during ASCO2023

By Hannah Ghinn

21.03.2023 | Article

Respiratory tracker: eHCPs raise awareness of inhaler use and ULEZ expansion for people with asthma

Bringing you the latest insights into online HCPs' respiratory disease related conversation

By Emily Fletcher-Louis

View all articles >